Applied Health Economics and Health Policy

Titel Veröffentlichungsdatum Sprache Zitate
Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review2014/01/03English45
Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia2008/01/01English45
The MAGEC System for Spinal Lengthening in Children with Scoliosis: A NICE Medical Technology Guidance2014/08/30English44
EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group2004/01/01English44
Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population2011/09/01English43
Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 20072010/09/01English43
Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications2016/09/01English42
WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology Guidance2014/03/25English42
Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review2016/02/12English42
Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data2014/06/12English42
Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists2014/06/29English42
The Cost Effectiveness of Long-Acting/Extended-Release Antipsychotics for the Treatment of Schizophrenia2013/03/14English41
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic2020/04/05English41
Generic Medicines: Solutions for a Sustainable Drug Market?2013/07/12English39
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review2018/07/17English39
Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis2014/01/24English38
A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries2013/10/26English38
Assessing the Cost Utility of Response-Guided Therapy in Patients with Chronic Hepatitis C Genotype 1 in the UK Using the MONARCH Model2012/11/14English38
Wealth Status and Risky Sexual Behaviour in Ghana and Kenya2008/01/01English38
Pre-Diagnosis Excess Acute Care Costs in Alzheimer’s Patients among a US Medicaid Population2013/05/23English37
Do Patients Always Prefer Quicker Treatment?2004/01/01English37
Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States2018/09/27English37
Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach2018/01/06English37
Amplifying Each Patient’s Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients2016/12/07English36
Nutrition Therapy Cost Analysis in the US2011/09/01English36
A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health2016/01/27English36
Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe2010/09/01English36
Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements2010/11/01English35
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients2016/08/04English35
The Effect of Protest Zeros on Estimates of Willingness to Pay in Healthcare Contingent Valuation Analysis2010/07/01English35